Colorado BioScience Association (CBSA) highlights Colorado’s key financings and acquisitions in the industry during 2013. The Association plays a key role in promoting Colorado as a dynamic region for bioscience innovation and investment.
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will tout Colorado’s growing medical device and diagnostic sectors during the ‘2014 AdvaMed: The MedTech Conference’ in Chicago, IL, October 6-8.
Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012. The deadline for entry is Friday, May 11th. Venture Showcase sponsors include Dorsey & Whitney LLP, EKS&H - Ehrhardt Keefe Steiner & Hottman PC, and the Metro Denver Economic Development Corporation.
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will tout Colorado’s growing medical device and diagnostic sectors during the ‘2014 AdvaMed: The MedTech Conference’ in Chicago, IL, October 6-8.
Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012. The deadline for entry is Friday, May 11th. Venture Showcase sponsors include Dorsey & Whitney LLP, EKS&H - Ehrhardt Keefe Steiner & Hottman PC, and the Metro Denver Economic Development Corporation.
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its Annual Awards Dinner at the Hyatt Convention Center, Denver. The celebration showcases the significant achievements from the bioscience industry throughout the past year.
De
The Education Committee of the Colorado BioScience Association (CBSA) is launching its new Internship Program with the support of 11 Founding Employers and the major universities in the state. Intern recruitment begins immediately through early spring 2012, with the first interns expected to be placed in positions by summer 2012.
Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education.
The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The BDEGP was created by the Colorado General Assembly in 2006 to grow the bioscience industry in the state.
The Colorado BioScience Association (CBSA) has announced finalists for the \'Rising Star of the Year\' company award at its 2012 Awards Dinner Celebration -- Thursday, December 6, at the Hyatt Convention Center, 650 15th Street, Denver. Rising Star finalists include: InDevR, Inc., Boulder; Mosaic Biosciences, Aurora & Boulder; Sophono, Inc., Boulder; and Surefire Medical, Inc., Westminster.
Three Colorado companies were selected to present at the 2014 ‘White Hat Life Science Investor Conference,’ in Phoenix, AZ. The Colorado companies included among the 34 presenting companies from across the region, were: EndoShape, Fluonic and ViroCyt.
Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver. The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood.
Colorado BioScience Association (CBSA) highlights Colorado’s key financings, acquisitions and expansions in the industry during 2014. CBSA plays a key role in promoting Colorado as a dynamic region for bioscience innovation and investment.
Companies from the Colorado Science + Technology Park at Fitzsimons will comprise about half of all presenters at this year’s Rocky Mountain Life Science Investor and Partnering Conference.
Located at the Brown Palace Hotel in Downtown Denver, the event will feature 30 presenting companies. The conference is organized by the Colorado BioScience Association as the Rocky Mountain region’s premier investor and partner conference.
Exhibitors will be showcasing new technologies, products and services for 300+ attendees at the 2014 BioWest Conference & Expo, September 10, at the Marriott City Center, Denver. Keynote speakers include Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office.
Colorado State University-CSU Ventures Annual Report 2014InnovatioNews
The 2014 Annual Report of CSU Ventures, the tech transfer and commercialization arm of Colorado State University.
4000+ Startup Companies spun off from American Universities 2013
14,995 New Patent Applications 2013
5198 Licenses executed in 2013
Innovations in engineering, bioscience, biomedical devices, agriculture and many others are supported by CSU Ventures. 2014 saw a dramatic increase in the number of active patents, active patent applications, active patents issued, active licenses and active startups.
Newly formed CSU Companies in 2014 include: Access Sensor Technology, Metrichip, Susmer, DeVirt, and Imeo Biologics.
Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. Bioscience Colorado is a key resource for companies, investors and economic developers, and has become the go-to source for the industry.
The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will host several keynote speakers who are shaping the future of bioscience. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.
Last week $3.135 Million in Commercialization Infrastructure grants were awarded by Colorado’s Office of Economic and International Trade (OEDIT) under the Bioscience Discovery Evaluation Grant Program (BDEGP). Colorado BioScience Association (CBSA) appreciates the OEDIT for its ongoing commitment to the state’s bioscience industry through the BDEGP, which was created in 2006 by the Colorado General Assembly.
Collaboration for Improving Outcomes- Regulatory Environment .docxmary772
Collaboration for Improving Outcomes- Regulatory Environment
Description: The baccalaureate graduate nurse will demonstrate basic knowledge of healthcare
policy, finance, and regulatory environments, including local, state, national, and global
healthcare trends.
Course Competency: 2) Develop a holistic case management plan for a specified disease or
population that incorporates the role of insurance, health care finance, and utilization of
community resources.
QSEN Competencies: 1) Patient-Centered Care 2) Teamwork and Collaboration 3) Evidence-
Based Practice
BSN Essential V
Area Gold
Mastery
Silver
Proficient
Bronze
Acceptable
Acceptable
Mastery not
Demonstrated
Evaluate Evaluates how
healthcare
exchanges can
change the concept
of outpatient
treatment
Discusses how
healthcare
exchanges can
change the concept
of outpatient
treatment
Lists how
healthcare
exchanges can
change the concept
of outpatient
treatment
Does not
address the
topic
Explain Explains the
advantages and
disadvantages of
embedding practice
guidelines and
clinical pathways
into electronic
medical record
systems
Discusses the
advantages and
disadvantages of
embedding
practice guidelines
and clinical
pathways into
electronic medical
record systems
Lists the advantages
and disadvantages
of embedding
practice guidelines
and clinical
pathways into
electronic medical
record systems
Does not
address the
topic
Describe Describe demand
management and
how it increases
consumer
involvement in care
Discusses demand
management and
how it increases
consumer
involvement in
care
Lists demand
management but
doesn’t discuss how
it increases
consumer
involvement in care
Does not
address the
topic
Compare
and Contrast
Compares and
contrasts disease
management and
case management
Discusses disease
management and
case management
Lists disease
management and
case management
Does not
address the
topic
APA,
Grammar,
Spelling,
and
Punctuation
No errors in APA,
Spelling, and
Punctuation.
One to three errors
in APA, Spelling,
and Punctuation.
Four to six errors in
APA, Spelling, and
Punctuation.
Seven or more
errors in APA,
Spelling, and
Punctuation.
References Provides two or
more references.
Provides two
references.
Provides one
references.
Provides no
references.
1st post
Sustainability and Green Management (triple bottom line) decisions in Operations.
Three components of the Triple Bottom Line (TBL) are people and community (social responsibility), planet (environmental sustainability) and profit (the bottom line). These three components are holding true today even with the current situation the world is dealing with the mass interruption of worldwide logistical efforts due to COVID 19. Bottom-line, profits have taking a back sea.
Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s Virocyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award.
My Great Great Grandmother Maria Christina, Great Great Grandfather George Conrad and their 'Baby Butz' are buried at Block 8, Lot 85. Their daughter and my Great Grandmother Susanna Katharina and Great Grandfather Johann Balthasar are buried at Block 13, Lot 262. Because I have family at this historic cemetery, we plan to participate in the Friends Society. Visit: http://friendsofriversidecemetery.org/
More Related Content
Similar to 2013 Proves Successful Year for Bioscience in Colorado
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its Annual Awards Dinner at the Hyatt Convention Center, Denver. The celebration showcases the significant achievements from the bioscience industry throughout the past year.
De
The Education Committee of the Colorado BioScience Association (CBSA) is launching its new Internship Program with the support of 11 Founding Employers and the major universities in the state. Intern recruitment begins immediately through early spring 2012, with the first interns expected to be placed in positions by summer 2012.
Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education.
The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The BDEGP was created by the Colorado General Assembly in 2006 to grow the bioscience industry in the state.
The Colorado BioScience Association (CBSA) has announced finalists for the \'Rising Star of the Year\' company award at its 2012 Awards Dinner Celebration -- Thursday, December 6, at the Hyatt Convention Center, 650 15th Street, Denver. Rising Star finalists include: InDevR, Inc., Boulder; Mosaic Biosciences, Aurora & Boulder; Sophono, Inc., Boulder; and Surefire Medical, Inc., Westminster.
Three Colorado companies were selected to present at the 2014 ‘White Hat Life Science Investor Conference,’ in Phoenix, AZ. The Colorado companies included among the 34 presenting companies from across the region, were: EndoShape, Fluonic and ViroCyt.
Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver. The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood.
Colorado BioScience Association (CBSA) highlights Colorado’s key financings, acquisitions and expansions in the industry during 2014. CBSA plays a key role in promoting Colorado as a dynamic region for bioscience innovation and investment.
Companies from the Colorado Science + Technology Park at Fitzsimons will comprise about half of all presenters at this year’s Rocky Mountain Life Science Investor and Partnering Conference.
Located at the Brown Palace Hotel in Downtown Denver, the event will feature 30 presenting companies. The conference is organized by the Colorado BioScience Association as the Rocky Mountain region’s premier investor and partner conference.
Exhibitors will be showcasing new technologies, products and services for 300+ attendees at the 2014 BioWest Conference & Expo, September 10, at the Marriott City Center, Denver. Keynote speakers include Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office.
Colorado State University-CSU Ventures Annual Report 2014InnovatioNews
The 2014 Annual Report of CSU Ventures, the tech transfer and commercialization arm of Colorado State University.
4000+ Startup Companies spun off from American Universities 2013
14,995 New Patent Applications 2013
5198 Licenses executed in 2013
Innovations in engineering, bioscience, biomedical devices, agriculture and many others are supported by CSU Ventures. 2014 saw a dramatic increase in the number of active patents, active patent applications, active patents issued, active licenses and active startups.
Newly formed CSU Companies in 2014 include: Access Sensor Technology, Metrichip, Susmer, DeVirt, and Imeo Biologics.
Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. Bioscience Colorado is a key resource for companies, investors and economic developers, and has become the go-to source for the industry.
The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will host several keynote speakers who are shaping the future of bioscience. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.
Last week $3.135 Million in Commercialization Infrastructure grants were awarded by Colorado’s Office of Economic and International Trade (OEDIT) under the Bioscience Discovery Evaluation Grant Program (BDEGP). Colorado BioScience Association (CBSA) appreciates the OEDIT for its ongoing commitment to the state’s bioscience industry through the BDEGP, which was created in 2006 by the Colorado General Assembly.
Collaboration for Improving Outcomes- Regulatory Environment .docxmary772
Collaboration for Improving Outcomes- Regulatory Environment
Description: The baccalaureate graduate nurse will demonstrate basic knowledge of healthcare
policy, finance, and regulatory environments, including local, state, national, and global
healthcare trends.
Course Competency: 2) Develop a holistic case management plan for a specified disease or
population that incorporates the role of insurance, health care finance, and utilization of
community resources.
QSEN Competencies: 1) Patient-Centered Care 2) Teamwork and Collaboration 3) Evidence-
Based Practice
BSN Essential V
Area Gold
Mastery
Silver
Proficient
Bronze
Acceptable
Acceptable
Mastery not
Demonstrated
Evaluate Evaluates how
healthcare
exchanges can
change the concept
of outpatient
treatment
Discusses how
healthcare
exchanges can
change the concept
of outpatient
treatment
Lists how
healthcare
exchanges can
change the concept
of outpatient
treatment
Does not
address the
topic
Explain Explains the
advantages and
disadvantages of
embedding practice
guidelines and
clinical pathways
into electronic
medical record
systems
Discusses the
advantages and
disadvantages of
embedding
practice guidelines
and clinical
pathways into
electronic medical
record systems
Lists the advantages
and disadvantages
of embedding
practice guidelines
and clinical
pathways into
electronic medical
record systems
Does not
address the
topic
Describe Describe demand
management and
how it increases
consumer
involvement in care
Discusses demand
management and
how it increases
consumer
involvement in
care
Lists demand
management but
doesn’t discuss how
it increases
consumer
involvement in care
Does not
address the
topic
Compare
and Contrast
Compares and
contrasts disease
management and
case management
Discusses disease
management and
case management
Lists disease
management and
case management
Does not
address the
topic
APA,
Grammar,
Spelling,
and
Punctuation
No errors in APA,
Spelling, and
Punctuation.
One to three errors
in APA, Spelling,
and Punctuation.
Four to six errors in
APA, Spelling, and
Punctuation.
Seven or more
errors in APA,
Spelling, and
Punctuation.
References Provides two or
more references.
Provides two
references.
Provides one
references.
Provides no
references.
1st post
Sustainability and Green Management (triple bottom line) decisions in Operations.
Three components of the Triple Bottom Line (TBL) are people and community (social responsibility), planet (environmental sustainability) and profit (the bottom line). These three components are holding true today even with the current situation the world is dealing with the mass interruption of worldwide logistical efforts due to COVID 19. Bottom-line, profits have taking a back sea.
Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s Virocyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award.
My Great Great Grandmother Maria Christina, Great Great Grandfather George Conrad and their 'Baby Butz' are buried at Block 8, Lot 85. Their daughter and my Great Grandmother Susanna Katharina and Great Grandfather Johann Balthasar are buried at Block 13, Lot 262. Because I have family at this historic cemetery, we plan to participate in the Friends Society. Visit: http://friendsofriversidecemetery.org/
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Company Valuation webinar series - Tuesday, 4 June 2024FelixPerez547899
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
In the Adani-Hindenburg case, what is SEBI investigating.pptxAdani case
Adani SEBI investigation revealed that the latter had sought information from five foreign jurisdictions concerning the holdings of the firm’s foreign portfolio investors (FPIs) in relation to the alleged violations of the MPS Regulations. Nevertheless, the economic interest of the twelve FPIs based in tax haven jurisdictions still needs to be determined. The Adani Group firms classed these FPIs as public shareholders. According to Hindenburg, FPIs were used to get around regulatory standards.
LA HUG - Video Testimonials with Chynna Morgan - June 2024Lital Barkan
Have you ever heard that user-generated content or video testimonials can take your brand to the next level? We will explore how you can effectively use video testimonials to leverage and boost your sales, content strategy, and increase your CRM data.🤯
We will dig deeper into:
1. How to capture video testimonials that convert from your audience 🎥
2. How to leverage your testimonials to boost your sales 💲
3. How you can capture more CRM data to understand your audience better through video testimonials. 📊
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
2013 Proves Successful Year for Bioscience in Colorado
1.
2013
Proves
Successful
Year
for
Bioscience
in
Colorado
Colorado
BioScience
Association
(CBSA)
highlights
Colorado’s
key
financings
and
acquisitions
in
the
industry
during
2013.
The
Association
plays
a
key
role
in
promoting
Colorado
as
a
dynamic
region
for
bioscience
innovation
and
investment.
Denver,
CO
–
December
17,
2013
–
Colorado
realized
a
number
of
key
financings
and
acquisitions
in
the
bioscience
industry
during
2013.
The
announcement
is
made
by
April
Giles,
President
&
CEO
of
the
Colorado
BioScience
Association
(CBSA),
who
says
"We
saw
several
exciting
deals
this
year
with
many
more
on
the
horizon
as
Colorado
continues
to
gain
national
recognition
in
the
bioscience
industry."
CBSA
plays
a
key
role
in
promoting
Colorado
as
a
dynamic
region
for
bioscience
innovation
and
investment,
by
working
with
government
and
community
stakeholders
to
develop
ways
to
support
the
creation,
retention
and
recruitment
of
life
sciences
companies.
Highlighted
Financing
and
Acquisitions
in
2013
Include
(deals
over
$8M):
•
Biodesix
Closes
$8.8M
Series
D
Financing
-‐
April
11,
2013
Boulder
based
Biodesix,
Inc.,
announced
that
the
company
closed
on
$8.8
million
in
a
follow-‐on
sale
of
its
Series
D
preferred
shares.
http://www.biodesix.com/biodesix-‐closes-‐series-‐d-‐financing-‐2/
•
Takeda
to
Acquire
Inviragen
for
$250M
–
May
8,
2013
Fort
Collins
based
Inviragen
agreed
to
be
acquired
by
Takeda,
the
largest
pharmaceutical
company
in
Japan
for
$35
million
cash
and
$215
million
in
milestones.
http://www.takeda.com/news/2013/20130508_5757.html
•
Lanx
Completes
$15M
Series
C
Equity
Financing
–
May
13,
2012
Broomfield
based
Lanx,
Inc.,
announced
the
closing
of
a
$15
million
Series
C
equity
financing.
http://www.lanx.com/pdfs/PR9900-‐0113_Series%20C%20Equity%20Financing%20Release.pdf
•
Clovis
Oncology
Raises
an
Additional
$275M
–
June
18,
2013
Boulder
based
Clovis
Oncology’s
initial
IPO
in
2011
was
$139
million
on
the
sale
of
10.7
million
shares.
They
raised
an
additional
$75
million
in
2012
and
$275
million
in
June
of
2013
through
public
offerings.
http://www.xconomy.com/boulder-‐denver/2013/06/18/clovis-‐oncology-‐closes-‐275m-‐offering-‐following-‐two-‐pivotal-‐weeks/
•
SomaLogic
Inc.
Raised
$10M
in
Equity
Financing
–
August
20,
2013
Boulder
based
SomaLogic
Inc.
raised
$10
million
in
equity
financing
from
unidentified
investors.
http://www.bizjournals.com/denver/blog/boosters_bits/2013/08/somalogic-‐raises-‐venture-‐capital.html
•
Baxter
Completes
Acquisition
of
Gambro
AB
for
$4B
–
September
6,
2013
Lakewood
based
Gambro
BCT,
a
wholly
owned
entity
of
Gambro
AB
was
acquired
by
Baxter
International
Inc.
of
Deerfield,
Ill
for
$4
billion.
http://www.baxter.com/press_room/press_releases/2013/09_06_13_gambro.html
•
Ampio
Pharmaceuticals,
Inc.
Announces
$25M
Financing
–
September
26,
2013
Greenwood
Village
based
Ampio
Pharmaceuticals,
Inc.
(NYSE
MKT:
AMPE)
announced
a
financing
transaction
that
will
provide
$25
million
in
gross
proceeds
to
the
company.
http://ampiopharma.com/news/ampio-‐pharmaceuticals-‐inc-‐announces-‐25-‐million-‐financing/
-‐More-‐
2. Page
2
•
Surefire
Medical
Closes
Series
B
Funding
at
$18.2M
-‐
November
7,
2013
Westminster
based
Surefire
Medical,
Inc.
completed
a
$18.2
million
Series
B
funding.
The
latest
financing
will
be
used
to
expand
product
development,
clinical
trials,
operations
and
marketing
to
meet
rapidly
growing
national
and
international
customer
demand.
http://surefiremedical.com/news/surefire-‐medical-‐closes-‐series-‐b-‐funding-‐at-‐18-‐2-‐million/
“Large
financings
and
acquisitions
are
key
to
raising
Colorado’s
profile
to
garner
attention
from
investors
and
corporate
leadership.
Colorado
has
all
of
the
pieces
in
place
to
be
in
the
top
5
national
bioscience
clusters
in
the
country—
the
science,
the
infrastructure,
and
the
people,"
Giles
explains.
About
Colorado
BioScience
Association
Celebrating
ten
years
of
supporting
the
Bioscience
Industry
in
Colorado
in
2013,
the
CBSA
is
a
not-‐for-‐profit
organization
providing
services
and
support
for
Colorado's
bioscience
industry.
With
more
than
350
members,
CBSA
actively
works
to
promote
the
growth
of
the
industry
by
advocating
for
a
better
business
environment,
growing
the
state's
biotech
workforce,
fighting
for
policies
that
support
a
strong
bioscience
industry
in
the
state,
and
speaking
with
a
single
voice
on
behalf
of
the
industry.
For
more
information,
visit
http://www.cobioscience.com.
CBSA
also
is
found
on
these
social
media
sites:
Twitter:
http://www.twitter.com/COBioscience
LinkedIn
Group:
http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook
Fan
Page:
http://www.facebook.com/ColoradoBioScienceAssociation
News
Feed:
http://coloradobio.blogspot.com
YouTube
Channel:
http://www.youtube.com/COBioscience
Pinterest:
http://pinterest.com/COBioscience
Tumblr:
http://cobioscience.tumblr.com
Contacts:
Mae
Desaire,
Director
of
Marketing,
Colorado
BioScience
Association
-‐
http://www.cobioscience.com
–
720-‐382-‐5918,
mdesaire@cobioscience.com
Maggie
Chamberlin
Holben,
APR,
Absolutely
Public
Relations
-‐
http://www.absolutelypr.com
-‐
303-‐984-‐9801,
maggie@absolutelypr.com